Inhaled NO has shown benefits as long term therapy for pulmonary arterial hypertension and other types of pulmonary hypertension. But the therapy also comes with some adverse effects (e.g., inflammation and oxidative damage to the lung) when used for a prolonged period of time. What recommendations would you make for weaning to ensure that the inhaled NO therapy is terminated safely?